Balanced news tone
News Sentiment
ACOG sentiment intelligence
Alpha Cognition Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
77/100 classification confidence.
directly relevant articles
high-authority source matches
+6.6% over one week, +40.4% over four weeks, trend active, and materially above fair value.
Raymond James Starts Alpha Cognition (ACOG) at Outperform
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Alpha Cognition Reports Positive Top-Line Results from BEACON Real-World Study of ZUNVEYL® in Alzheimer’s Disease
- Tone
- Positive 58/100
- Event
- Earnings
- Published
- 09 Jun 2026 12:00
- Source
- Business Wire
Alpha Cognition Inc. (NASDAQ:ACOG) Just Reported, And Analysts Assigned A US$16.00 Price Target
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 17 May 2026 07:00
- Source
- Market source
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
ALPHA COGNITION ($ACOG) Releases Q1 2026 Earnings, Stock Rises
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Quiver Quantitative
Alpha Cognition Inc. (ACOG) Reports Q1 Loss, Tops Revenue Estimates
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Alpha Cognition Inc. (ACOG) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 07 May 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
Alpha Cognition Inc.'s (NASDAQ:ACOG) Path To Profitability
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Apr 2026 07:00
- Source
- Market source
Alpha Cognition Inc. (ACOG) Soars 8.6%: Is Further Upside Left in the Stock?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 02 Apr 2026 07:00
- Source
- qz.com
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView
Alpha Cognition Inc. Reports Fiscal 2025 Financial Results and Provides Operational Update
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Mar 2026 07:00
- Source
- BioSpace
ALPHA COGNITION ($ACOG) Releases Q4 2025 Earnings | ACOG Stock News
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 26 Mar 2026 07:00
- Source
- Quiver Quantitative
Alpha Cognition Inc. (ACOG) Reports Q4 Loss, Lags Revenue Estimates
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 26 Mar 2026 07:00
- Source
- Market source
Alpha Cognition Announces Proposed Financing and Share Consolidation in connection with Nasdaq Uplisting
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 31 Oct 2024 07:00
- Source
- Business Wire
FDA Approves Alpha Cognition’s Zunveyl as Oral Therapy for Mild-to-Moderate Alzheimer Disease
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jul 2024 07:00
- Source
- Pharmaceutical Executive